Krystal Biotech Inc
(KRYS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,459 | -4,111 | -10,889 | -7,181 | -4,426 |
| Depreciation Amortization | 452 | 199 | 141 | 80 | 42 |
| Accounts payable and accrued liabilities | 490 | 583 | 112 | 129 | 21 |
| Other Working Capital | 828 | 384 | 511 | 684 | 185 |
| Other Operating Activity | 265 | -270 | 680 | 361 | 191 |
| Operating Cash Flow | $-7,424 | $-3,215 | $-9,445 | $-5,927 | $-3,987 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -773 | -512 | -8,089 | -5,626 | -3,639 |
| PPE Investments | -2,945 | -1,707 | -2,234 | -930 | -98 |
| Other Investing Activity | 0 | -263 | 0 | 0 | -64 |
| Investing Cash Flow | $-3,718 | $-2,482 | $-10,323 | $-6,556 | $-3,801 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 94,059 | 40 | 73,847 | 9,559 | 10 |
| Financing Cash Flow | $94,059 | $40 | $73,847 | $9,559 | $10 |
| Beginning Cash Position | 103,670 | 103,670 | 49,591 | 49,591 | 49,591 |
| End Cash Position | 186,587 | 98,013 | 103,670 | 46,667 | 41,813 |
| Net Cash Flow | $82,917 | $-5,657 | $54,079 | $-2,924 | $-7,778 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,424 | -3,215 | -9,445 | -5,927 | -3,987 |
| Capital Expenditure | -2,945 | -1,707 | -2,234 | -930 | -98 |
| Free Cash Flow | -10,369 | -4,922 | -11,679 | -6,857 | -4,085 |